WQ1 logo

MedApp DB:WQ1 Stock Report

Last Price

€0.031

Market Cap

€9.7m

7D

9.9%

1Y

-56.3%

Updated

08 Jan, 2025

Data

Company Financials

WQ1 Stock Overview

Develops solutions to support diagnostic imaging and digital medicine in Poland. More details

WQ1 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

MedApp S.A. Competitors

Price History & Performance

Summary of share price highs, lows and changes for MedApp
Historical stock prices
Current Share Pricezł0.031
52 Week Highzł0.079
52 Week Lowzł0.027
Beta0.92
1 Month Change-1.27%
3 Month Change-9.83%
1 Year Change-56.30%
3 Year Change-86.26%
5 Year Changen/a
Change since IPO-84.40%

Recent News & Updates

Recent updates

Shareholder Returns

WQ1DE Healthcare ServicesDE Market
7D9.9%-0.007%2.0%
1Y-56.3%-17.8%9.6%

Return vs Industry: WQ1 underperformed the German Healthcare Services industry which returned -17.8% over the past year.

Return vs Market: WQ1 underperformed the German Market which returned 9.6% over the past year.

Price Volatility

Is WQ1's price volatile compared to industry and market?
WQ1 volatility
WQ1 Average Weekly Movement6.9%
Healthcare Services Industry Average Movement6.3%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.7%
10% least volatile stocks in DE Market2.4%

Stable Share Price: WQ1 has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: WQ1's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
201022David Odrakiewiczmedapp.pl

MedApp S.A. develops solutions to support diagnostic imaging and digital medicine in Poland. The company offers CarnaLife System, an analytical telemedicine system that enables physician to assess and monitor the health of patients and conduct consultations, as well as enable remote measurement, such as pulse oximeter, electrocardiograph, blood pressure monitor, thermometer, scale, auscultation device, and others. It also offers CarnaLife Holo, a 3D imaging system for 3D visualization imaged medical data, which supports the planning and performance of medical procedures; Digital Clinic that offers remote medical care, medical consultations, diagnostics, and in-depth health monitoring; and HoloComm for remote product demonstration in 3D.

MedApp S.A. Fundamentals Summary

How do MedApp's earnings and revenue compare to its market cap?
WQ1 fundamental statistics
Market cap€9.74m
Earnings (TTM)-€962.03k
Revenue (TTM)€1.25m

7.8x

P/S Ratio

-10.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
WQ1 income statement (TTM)
Revenuezł5.33m
Cost of Revenuezł1.05m
Gross Profitzł4.28m
Other Expenseszł8.39m
Earnings-zł4.11m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.016
Gross Margin80.27%
Net Profit Margin-77.14%
Debt/Equity Ratio7.4%

How did WQ1 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 00:10
End of Day Share Price 2025/01/08 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

MedApp S.A. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Adrian KowollikEast Value Research GmbH